Ambalalrabhai EnterprisesBOM:500009 -0.90%70 Net Margin % is 9.93% as of Mar. 2026, which is 98% above its 10-year median of 5.02. GuruFocus rates BOM:500009 with a GF Score™ of 70/100 and a GF Value™ of ₹41.67 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 962 Drug Manufacturers companies, Ambalalrabhai Enterprises ranks better than 59.25% on this metric.
The historical rank and industry rank for Ambalalrabhai Enterprises's Net Margin % or its related term are showing as below:
BOM:500009'
s Net Margin % Range Over the Past 10 Years
Min: -13.61 Med: 5.02 Max: 24.23
Current: 8.52
BOM:500009's Net Margin % is ranked better than 59.25% of 962
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs BOM:500009: 8.52
Ambalalrabhai Enterprises (BOM:500009) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Ambalalrabhai Enterprises Net Margin % Related Terms
Ambalalrabhai Enterprises Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Ambalalrabhai Enterprises's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambalalrabhai Enterprises Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ambalalrabhai Enterprises's Net Margin % distribution charts can be found below:
* The bar in red indicates where Ambalalrabhai Enterprises's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ambalalrabhai Enterprises (BOM:500009) has a Net Margin % of 9.93% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Ambalalrabhai Enterprises and its competitors. This is 98% above median its historical median of 5.02. According to the industry distribution chart, Ambalalrabhai Enterprises ranks #392 out of 962 companies in the Drug Manufacturers industry, placing it in the top 40.7%.
Is Ambalalrabhai Enterprises' Net Margin % too high?
Ambalalrabhai Enterprises' current Net Margin % of 9.93% is 98% above median its 10-year median of 5.02. The Drug Manufacturers industry median Net Margin % is 5.56. Ambalalrabhai Enterprises' value of 9.93% is 78.6% above this industry median. Based on the distribution chart, Ambalalrabhai Enterprises ranks #392 out of 962 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Ambalalrabhai Enterprises has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambalalrabhai Enterprises' Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ambalalrabhai Enterprises ranks #392 out of 962 companies for Net Margin %. This puts Ambalalrabhai Enterprises in the upper half of its industry. The industry median Net Margin % is 5.56. Ambalalrabhai Enterprises' value of 9.93% is 78.6% above this benchmark. While the company's 10-year median is 5.02 vs. the industry median of 5.56, Ambalalrabhai Enterprises has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ambalalrabhai Enterprises's current Net Margin % of 9.93% is 78.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Ambalalrabhai Enterprises and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambalalrabhai Enterprises's current Net Margin % is 9.93%, which is 98% above median its own 10-year median of 5.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambalalrabhai Enterprises stock overvalued right now?
Based on GuruFocus' analysis, Ambalalrabhai Enterprises (BOM:500009) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹41.67, compared to a current price of ₹30.82 — trading 26% below its estimated fair value. The current Net Margin % is 9.93%, which is 98% above median its 10-year median of 5.02 and 78.6% above the Drug Manufacturers industry median of 5.56. Ambalalrabhai Enterprises' overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Ambalalrabhai Enterprises (BOM:500009), the current Net Margin % is 9.93% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambalalrabhai Enterprises (BOM:500009) Overvalued in 2026?
Based on GuruFocus' analysis, Ambalalrabhai Enterprises stock appears to be undervalued.
The current stock price of ₹30.82 is trading 26% below its estimated GF Value™ of ₹41.67.
GuruFocus considers Ambalalrabhai Enterprises to be Modestly Undervalued.
Key valuation signals for BOM:500009:
Net Margin %: 9.93% (98% above median its 10-year median of 5.02)
GF Value™: ₹41.67 vs. price of ₹30.82 (26% below fair value)
Industry Position: 78.6% above the Drug Manufacturers median (#392 of 962)
No single metric tells the full story. See the BOM:500009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambalal Sarabhai Enterprises Ltd is an India-based company engaged in the manufacturing and marketing of Drugs and Formulation. The operating segment of the company is Pharmaceutical Products. It serves domestic as well as International markets.
70GF Score
Get the complete analysis for BOM:500009
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500009 has been successfully added to your 
